Pacira BioSciences (PCRX) Tax Provisions (2013 - 2026)
Pacira BioSciences' Tax Provisions was -$2.1 million in Q2 2026, compared with $2.92 million a year earlier.
Powered by 
Analysis
Pacira BioSciences (PCRX) Tax Provisions (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pacira BioSciences' Tax Provisions was $3.01 million through Jun 30, 2026, down 85.6% year-over-year; for FY2025, it was $9.84 million, down 73.0% from FY2024.
- In earlier years, Tax Provisions was $36.45 million in FY2024 (+84.6%), $19.75 million in FY2023, -$2.61 million in FY2022 and $14.42 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Tax Provisions since Q1 2023.
- Compared with a year earlier, Tax Provisions was higher in 1 of the last six quarters, with an average decline of 28.4%.
- The best year-over-year quarter for Tax Provisions over five years was Q2 2023 (growth of 467.4%); the worst was Q2 2025 (a decline of 83.5%).
- Per Business Quant data, PCRX's Tax Provisions in the three quarters before Q2 2026 was $2.08 million (Q1 2026), -$1.07 million (Q4 2025) and $4.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -1.01 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -291.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 393.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 242.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -407.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 292.00 Mn |
| 10 | Pacira BioSciences | 997.55 Mn | 59.58 Mn | 148.24 Mn | -2.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.10 Mn |
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | 2.92 Mn |
| Mar 31, 2025 | 3.89 Mn |
| Dec 31, 2024 | 9.49 Mn |
| Sep 30, 2024 | 4.61 Mn |
| Jun 30, 2024 | 17.70 Mn |
| Mar 31, 2024 | 4.66 Mn |
| Dec 31, 2023 | 8.85 Mn |
| Sep 30, 2023 | 5.74 Mn |
| Jun 30, 2023 | 12.09 Mn |
| Mar 31, 2023 | -6.94 Mn |
| Dec 31, 2022 | -7.97 Mn |
| Sep 30, 2022 | 2.76 Mn |
| Jun 30, 2022 | 2.13 Mn |
| Mar 31, 2022 | 466,000.00 |
| Dec 31, 2021 | -1.07 Mn |
| Sep 30, 2021 | 6.57 Mn |
API Access
Pacira BioSciences Tax Provisions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-provisions&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-provisions", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=tax-provisions&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();